Stay updated on VRDN 001 Safety and Efficacy in TED Clinical Trial
Sign up to get notified when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.

Latest updates to the VRDN 001 Safety and Efficacy in TED Clinical Trial page
- Check4 days agoChange DetectedThe webpage has undergone significant changes, including the removal of a service alert regarding planned maintenance and detailed information about a clinical trial for the drug veligrotug (VRDN-001) for thyroid eye disease. Additionally, there are new disclaimers about the security of the website and its official status as a U.S. government site.SummaryDifference100%
- Check12 days agoChange DetectedThe web page has been updated to reflect the completion of the recruitment phase for the clinical trial of the investigational drug veligrotug (VRDN-001) for thyroid eye disease (TED), with new details on study locations and key inclusion/exclusion criteria for participants. Additionally, the primary objective of the trial has been clarified, focusing on the safety, tolerability, and efficacy of veligrotug.SummaryDifference78%
- Check19 days agoChange DetectedThe web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.SummaryDifference0.9%
- Check26 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check47 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
Stay in the know with updates to VRDN 001 Safety and Efficacy in TED Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.